El Salvador vs Saudi Arabia: Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage
El Salvador
96.0%
in 2024
Saudi Arabia
96.0%
in 2024
El Salvador rank
15th
Saudi Arabia rank
15th
Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage over time
- El Salvador
- Saudi Arabia
How they compare
El Salvador currently reports 96.0% against 96.0% in Saudi Arabia, a difference of 0.0%.
The two have swapped places 4 times across 15 shared years of data; in 2010 it was Saudi Arabia ahead.
El Salvador ranks 15th and Saudi Arabia ranks 15th of 146 countries.
Saudi Arabia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | El Salvador | Saudi Arabia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 91.0% | 97.8% | 6.8% | Saudi Arabia |
| 2020s | 94.0% | 96.6% | 2.6% | Saudi Arabia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage, El Salvador or Saudi Arabia?
- El Salvador, at 96.0% against 96.0% in Saudi Arabia as of 2024.
- What is the difference in pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage between El Salvador and Saudi Arabia?
- 0.0%, with El Salvador ahead.
- How many years of comparable data are there for El Salvador and Saudi Arabia?
- 15 years are reported by both, from 2010 to 2024.
- How do El Salvador and Saudi Arabia rank globally for pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage?
- El Salvador ranks 15th and Saudi Arabia ranks 15th of 146 countries.
- Where does this data come from?
- WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data, published as Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of one-year-olds who have had the third dose of the pneumococcal conjugate vaccine in a given year.